ang
import
role
prevent
acut
lung
injuri
howev
clear
whether
upregul
ma
axi
prevent
lpsinduc
injuri
pulmonari
microvascular
endotheli
cell
pmvec
inhibit
mapksnfkb
pathway
primari
cultur
rat
pmvec
transduc
lentiviralborn
treat
ma
receptor
blocker
exposur
lp
lp
stimul
result
higher
level
angii
ang
cytokin
secret
apoptosi
rate
lower
ratio
revers
imbal
increas
ang
level
thu
reduc
lpsinduc
apoptosi
inflamm
inhibit
revers
effect
abolish
protect
effect
lp
treatment
associ
activ
erk
jnk
nfkb
pathway
aggrav
pretreat
prevent
blockad
jnk
nfkb
phosphoryl
howev
jnk
inhibitor
markedli
reduc
apoptosi
cytokin
secret
pmvec
delet
pretreat
result
suggest
ma
axi
crucial
role
prevent
lpsinduc
apoptosi
inflamm
pmvec
inhibit
jnknfkb
pathway
cute
respiratori
distress
syndrom
ard
inflammatori
respons
pulmonari
extrapulmonari
stimuli
character
acut
onset
new
worsen
respiratori
dysfunct
despit
improv
intens
care
optim
ventil
support
fluid
balanc
mortal
patient
ard
remain
diffus
pulmonari
endotheli
cell
injuri
result
impair
alveolarcapillari
barrier
increas
microvascular
endotheli
permeabl
consid
central
pathogenesi
ard
reninangiotensin
system
ra
complex
hormon
system
pivot
regul
maintain
homeostasi
blood
pressur
electrolyt
balanc
ra
also
import
role
inflamm
abnorm
activ
ra
involv
pathogenesi
cardiovascular
renal
lung
diseas
angiotensinconvert
enzym
ace
homologu
ace
recent
discov
compon
ra
contrast
ace
convert
angiotensin
ang
angi
gener
angii
reduc
gener
angii
catalyz
convers
angii
ang
attenu
vasoconstrict
prolif
inflammatori
effect
angii
henc
pertin
role
antiinflammatori
axi
counteract
proinflammatori
effect
aceangii
axi
membraneassoci
aminopeptidas
vascular
endothelia
renal
cardiovascular
tissu
epithelia
small
intestin
test
also
broadli
express
almost
kind
cell
type
lung
includ
endotheli
smooth
muscl
cell
blood
vessel
type
ii
alveolar
epitheli
cell
bronchial
epitheli
cell
also
evid
import
role
develop
ard
fact
level
posit
correl
sever
acut
respiratori
syndrom
sar
coronaviru
infect
human
airway
epithelia
addit
mice
suffer
aggrav
lung
injuri
compar
wildtyp
mice
model
ard
wherea
therapi
recombin
improv
ard
especi
wildtyp
mice
find
suggest
may
prevent
lung
injuri
may
use
therapeut
agent
target
ard
sever
studi
shown
mitogenactiv
protein
kinas
mapk
may
key
role
acut
lung
injuri
exampl
inhibit
mapk
phosphoryl
activ
protect
pulmonari
infiltr
leukocyt
well
lung
edema
activ
mapk
appear
import
upstream
signal
event
associ
tumor
necrosi
factor
tnf
ainduc
barrier
failur
pulmonari
endotheli
monolay
furthermor
inhibit
mapk
extracellular
signal
regul
kinas
erk
significantli
attenu
tnfainduc
increas
endotheli
permeabl
mapk
pathway
also
mediat
regul
mrna
express
rat
aortic
vascular
smooth
muscl
cell
lipopolysaccharid
lp
releas
gramneg
bacteri
cell
wall
contribut
pulmonari
inflamm
sepsi
lead
ard
upon
recognit
tolllik
receptor
cellular
surfac
lp
activ
nuclear
factorkb
nfkb
mapk
cascad
lead
releas
proinflammatori
cytokin
interleukin
il
tnfa
signal
regul
sever
acut
lung
injuri
ali
mapk
erk
nfkb
activ
lpsinduc
lung
injuri
inhibit
erk
prevent
lpsinduc
inflamm
suppress
nfkb
transcript
activ
inhibit
mapk
attenu
pulmonari
inflammatori
respons
induc
lp
reduc
activ
nfkb
found
benefici
cardiac
pulmonari
protect
instanc
inhibit
cardiac
fibrosi
reduct
erk
phosphoryl
telmisartan
protect
heart
failur
upregul
ma
receptor
axi
inhibit
express
mapk
phosphocjun
ntermin
kinas
jnk
phosphoerk
phosphomapkactiv
protein
furthermor
upregul
lessen
lung
injuri
angiotensin
import
role
prevent
ard
howev
whether
upregul
ma
axi
prevent
lpsinduc
apoptosi
pulmonari
microvascular
endotheli
cell
inhibit
mapksnfkb
pathway
remain
unknown
present
studi
investig
whether
upregul
express
may
prevent
lpsinduc
pulmonari
inflamm
cytotox
way
mapknfkb
signal
pathway
reagent
lp
escherichia
coli
purchas
sigmaaldrich
st
loui
mo
usa
rabbit
antiac
mous
antiikba
antibodi
procur
santa
cruz
biotechnolog
delawar
ca
usa
rabbit
mapk
mapk
antistressactiv
protein
kinas
sapk
jnk
antiphosphosapkjnk
horseradish
peroxidas
hrp
conjug
secondari
antibodi
goat
antirabbit
igg
hors
antimous
igg
antibodi
purchas
cell
signal
technolog
danver
usa
tnfa
kit
purchas
invitrogen
eugen
usa
angii
ang
enzymelink
immunosorb
assay
elisa
kit
came
kamiya
biomed
seattl
wa
usa
ma
receptor
blocker
obtain
abbiotech
san
diego
ca
usa
specif
inhibitor
mapk
specif
inhibitor
specif
inhibitor
jnk
purchas
santa
cruz
biotechnolog
delawar
ca
usa
anim
spraguedawley
rat
weigh
g
obtain
depart
laboratori
anim
scienc
fudan
univers
shanghai
china
anim
handl
accord
protocol
approv
ethic
committe
anim
research
colleg
medicin
shanghai
jiaotong
univers
shanghai
china
cell
cultur
isol
cultur
pulmonari
microvascular
endotheli
cell
pmvec
perform
describ
previous
briefli
rat
euthan
intraperiton
inject
pentobarbit
sodium
thoracotomi
perform
lung
circulatori
system
perfus
inject
ml
icecold
phosphat
buffer
salin
pb
via
right
ventricl
lung
remov
wash
ml
icecold
serumfre
dulbecco
modifi
eagl
medium
dmem
sigmaaldrich
st
loui
mo
usa
pleura
care
cut
away
discard
section
mm
cut
outer
edg
remain
lung
tissu
trim
small
piec
lung
tissu
piec
insert
glass
pellet
costar
cambridg
rins
endotheli
cell
medium
sciencel
research
carlsbad
ca
usa
supplement
fetal
calf
serum
uml
penicillinstreptomycin
gml
amphotericin
b
glass
pellet
incub
humidifi
air
co
h
cultur
media
replac
everi
day
cell
confluenc
harvest
treat
trypsinethylenediaminetetraacet
acid
edta
gibco
grand
island
ny
usa
subcultur
ratio
cobbleston
morpholog
immunostain
rabbit
antihuman
factor
viii
antirat
boster
wuhan
china
fluorescein
isothiocyan
fitc
bandeiraea
simplicifolia
isolectin
bsi
santa
cruz
delawar
ca
usa
use
identifi
endotheli
cell
third
fifth
cell
passag
use
follow
experi
gener
recombin
small
hairpin
rna
shrna
lentivirus
total
rna
extract
rat
pmvec
revers
transcrib
cdna
use
mmlv
revers
transcriptas
takara
bio
japan
cdna
use
amplifi
code
sequenc
follow
primer
forward
revers
three
shrna
sequenc
target
rat
code
region
homolog
nt
mrna
respect
design
small
interf
rna
sirna
invalid
rna
interfer
rnai
sequenc
use
neg
control
correspond
oligonucleotid
templat
shrna
chemic
synthes
pcr
product
purifi
ligat
lentivir
pcdnacmvcopgfp
cdna
vector
synthes
shrna
system
bioscienc
ca
usa
ligat
mixtur
transform
compet
e
coli
strain
result
plasmid
confirm
sequenc
accord
manufactur
instruct
vector
carri
shrna
lentiviru
packag
plasmid
cotransfect
produc
cell
use
lipofectamin
invitrogen
carlsbad
ca
usa
supernat
collect
h
later
total
rna
protein
extract
determin
mrna
protein
select
recombin
shrna
lentiviru
suffici
sirna
viral
titer
evalu
gradient
dilut
recombin
lentivirus
name
lentivir
transduct
one
day
seed
pmvec
cell
infect
dilut
multipl
infect
moi
endotheli
cell
medium
refresh
h
later
infect
effici
assess
fluoresc
microscopi
h
infect
one
hundr
microlit
pmvec
normal
lentivirusinfect
seed
plate
cellswel
incub
serumfre
dmem
h
pmvec
whether
normal
infect
pretreat
nm
h
stimul
mgml
lp
h
follow
normal
cell
pb
untreat
control
normal
cell
treat
without
lp
normal
cell
treat
lp
lp
normal
cell
treat
also
lp
lp
cell
infect
empti
control
viru
receiv
lp
lvcontrol
lp
cell
infect
rnai
neg
control
nc
receiv
lp
lvnc
lp
cell
infect
receiv
lp
lp
cell
infect
receiv
lp
lp
cell
infect
receiv
prior
lp
lp
experi
use
specif
mapk
inhibitor
normal
cell
cell
infect
preincub
either
mm
mm
mm
hour
exposur
lp
apoptosi
assay
apoptosi
determin
use
annexin
vfitc
apoptosi
detect
kit
bd
franklin
lake
nj
usa
accord
manufactur
protocol
brief
cell
harvest
wash
time
pb
centrifug
g
min
resuspend
ml
bind
buffer
hepe
naoh
nacl
mm
cacl
ph
final
concentr
cell
ml
incub
ml
annexin
vfitc
min
ml
propidium
iodid
min
room
temperatur
cell
suspens
subject
flow
cytometri
facscalibur
bd
franklin
lake
nj
usa
detect
excit
wavelength
nm
data
analyz
use
cellquest
pro
softwar
bd
franklin
lake
nj
usa
detect
cytokin
secret
cultur
supernat
group
collect
frozen
tnfa
angii
ang
concentr
supernat
assay
sandwich
elisa
briefli
plate
coat
monoclon
antibodi
specif
tnfa
angii
ang
suppli
elisa
kit
elisa
perform
accord
manufactur
instruct
final
absorb
nm
measur
use
micropl
reader
biorad
laboratori
hercul
ca
usa
concentr
extrapol
standard
curv
obtain
plate
western
blot
analysi
total
protein
extract
cell
use
mper
mammalian
protein
extract
reagent
pierc
il
usa
protein
concentr
determin
bicinchonin
acid
protein
assay
kit
pierc
usa
equal
amount
protein
mg
run
sdspage
gel
transfer
onto
nitrocellulos
membran
membran
block
skim
milk
trisbuff
salin
mm
tri
mm
nacl
tween
tbst
room
temperatur
h
blot
probe
primari
antibodi
rat
ace
sapkjnk
mapk
ikba
phosphoryl
b
actin
wash
tbst
blot
incub
secondari
hrpconjug
antimouserabbit
igg
wash
tbst
time
membran
develop
chemiluminesc
ecl
detect
kit
imag
xray
film
beta
actin
use
endogen
refer
normal
statist
analys
data
present
mean
standard
deviat
sd
statist
analys
perform
prism
softwar
packag
graphpad
san
diego
ca
usa
data
analyz
use
oneway
anova
newmankeul
test
multipl
comparison
pvalu
less
accept
statist
signific
effect
masreceptor
antagonist
lpsinduc
apoptosi
pmvec
rate
apoptosi
pmvec
lp
group
expos
lp
h
significantli
higher
pb
control
group
p
fig
cell
infect
receiv
lp
lp
group
rate
apoptosi
p
significantli
lower
pmvec
infect
treat
lp
lp
group
p
normal
pmvec
stimul
lp
apoptosi
rate
given
pretreat
lp
group
significantli
higher
cell
treat
lp
lp
p
fig
howev
apoptosi
rate
cell
infect
receiv
pretreat
prior
lp
lp
group
significantli
lower
lp
group
p
although
signific
differ
lp
group
lp
group
effect
masreceptor
antagonist
cytokin
secret
pmvec
tnfa
level
supernat
cultur
pmvec
expos
lp
h
significantli
higher
compar
control
group
fig
lpsinduc
tnfa
secret
significantli
inhibit
overexpress
promot
knockdown
pmvec
expos
lp
pretreat
caus
signific
increas
tnfa
secret
markedli
attenu
overexpress
fig
howev
signific
differ
lp
lpstreat
cell
level
cytokin
supernat
result
indic
suppress
lpsinduc
inflammatori
respons
pmvec
masreceptor
antagonist
effect
prevent
protect
effect
effect
masreceptor
antagonist
angiiang
secret
pmvec
angii
level
supernat
lp
group
ngml
significantli
higher
pb
control
group
ngml
p
ang
level
lp
group
slightli
higher
ngml
pb
group
ngml
p
cell
infect
receiv
lp
lp
group
angii
secret
ngml
significantli
less
normal
cell
receiv
lp
lp
group
ngml
angii
level
significantli
higher
pmvec
infect
treat
lp
lp
group
ngml
compar
lp
group
p
contrast
ang
level
pmvec
infect
receiv
lp
lp
group
ngml
p
significantli
higher
lp
group
ngml
also
lp
group
ngml
p
fig
normal
pmvec
expos
lp
angii
level
pretreat
lp
group
ngml
significantli
higher
cell
treat
lp
ngml
p
angii
level
cell
infect
receiv
pretreat
prior
lp
lp
group
ngml
significantli
lower
lp
group
ngml
p
howev
level
ang
normal
pmvec
treat
lp
lp
group
ngml
slightli
less
level
lp
group
p
lp
group
ng
ml
slightli
higher
p
fig
effect
masreceptor
antagonist
ace
ratio
pmvec
rel
normal
pmvec
pb
control
group
stimul
lp
h
lp
group
ace
level
higher
level
lower
therefor
ratio
significantli
lower
fig
howev
cell
infect
receiv
lp
lp
group
ratio
compar
control
group
p
contrast
cell
infect
receiv
lp
lp
group
ratio
ace
ratio
lower
lp
group
compar
aceactin
level
lp
group
respect
significantli
lower
normal
pmvec
treat
prior
lp
lp
group
p
ratio
also
notabl
lower
lp
group
compar
control
group
significantli
differ
lp
group
fig
addit
compar
aceactin
level
normal
cell
treat
lp
lp
group
respect
cell
infect
treat
lp
lp
group
significantli
higher
p
aceactin
similar
p
result
ratio
much
higher
lp
group
effect
masreceptor
antagonist
mapk
phosphoryl
pmvec
western
blot
result
show
normal
pmvec
incub
lp
h
lp
group
phosphoryl
level
sapkjnk
significantli
higher
compar
untreat
control
group
fig
compar
lp
group
pmvec
transduc
incub
lp
lp
group
lower
level
phosphoryl
sapkjnk
level
phosphoryl
markedli
less
contrast
compar
lp
group
pmvec
transduc
incub
lp
lp
group
significantli
higher
phosphoryl
level
level
phosphoryl
sapkjnk
similar
pretreat
lpsexpos
cell
lp
group
associ
significantli
higher
phosphoryl
level
three
mapk
pathway
rel
cell
lp
group
wherea
compar
lp
group
level
phosphoryl
sapkjnk
phosphoryl
lp
group
markedli
lower
p
obviou
differ
level
lp
lp
group
p
fig
f
furthermor
compar
lp
group
phosphoryl
level
slightli
less
lp
group
p
significantli
higher
lp
group
phosphoryl
level
lp
group
still
enhanc
lp
group
p
addit
level
phosphoryl
lp
group
approxim
lp
group
p
level
phosphoryl
sapk
jnk
significantli
higher
p
effect
masreceptor
antagonist
nfkb
phosphoryl
ikba
express
pmvec
phosphoryl
nfkb
express
ikba
examin
western
blot
fig
lp
stimul
result
significantli
increas
level
nfkb
phosphoryl
decreas
level
ikba
express
normal
pmvec
cell
infect
stimul
lp
lp
group
nfkb
phosphoryl
level
significantli
lower
ikba
express
level
significantli
higher
pmvec
stimul
lp
contrast
compar
lp
group
pmvec
transduc
stimul
lp
lp
group
significantli
higher
nfkb
phosphoryl
level
lower
ikba
express
level
phosphoryl
level
nfkb
significantli
higher
ikba
level
lower
cell
stimul
lp
pretreat
lp
group
compar
lp
group
phosphoryl
nfkb
level
lp
group
significantli
higher
lp
group
significantli
differ
lp
lp
group
ikba
level
lp
group
approxim
similar
lp
group
significantli
increas
compar
lp
group
pmvec
clarifi
whether
inhibit
mapk
activ
influenc
effect
masreceptor
antagonist
lpsinduc
pmvec
apoptosi
cell
preincub
mapk
signal
pathway
specif
inhibitor
lp
stimul
fig
compar
apoptosi
level
lp
group
pretreat
without
pretreat
significantli
inhibit
lpsinduc
apoptosi
normal
transduc
pmvec
apoptosi
level
lp
lp
lp
lp
group
respect
p
apoptosi
cell
infect
stimul
lp
significantli
increas
pretreat
lp
group
compar
lp
lp
group
respect
p
apoptosi
level
cell
infect
pretreat
prior
lp
stimul
significantli
higher
lp
group
lp
lp
group
respect
compar
lp
group
p
pretreat
affect
apoptosi
cell
infect
normal
cell
pretreat
lp
stimul
lp
lp
lp
lp
lp
group
compar
lp
group
p
cell
infect
stimul
lp
lp
group
pretreat
specif
mapk
signal
inhibitor
affect
lpsinduc
tnfa
secret
fig
contrast
pretreat
mapk
signal
inhibitor
especi
pretreat
pmvec
transduc
stimul
lp
lp
group
significantli
suppress
cytokin
secret
fig
pmvec
expos
lp
pretreat
significantli
increas
slightli
reduc
significantli
attenu
tnfa
secret
fig
addit
preincub
affect
lpsinduc
tnfa
secret
cell
infect
pretreat
prior
lp
stimul
lp
group
lpsinduc
tnfa
secret
lp
group
significantli
inhibit
preincub
fig
present
studi
investig
effect
overexpress
shrnainhibit
lpsinduc
injuri
lentivirustran
decreas
ratio
pmvec
markedli
revers
overexpress
aggrav
downregul
b
ratio
greatli
reduc
pretreat
prior
lp
stimul
revers
overexpress
differ
ratio
lp
lp
group
data
express
mean
sd
p
compar
control
group
p
compar
lp
group
wwwnaturecomscientificreport
scientif
report
doi
duce
pmvec
found
overexpress
attenu
apoptosi
tnfa
secret
caus
lp
stimul
delet
ma
receptor
inhibit
exhibit
almost
similar
deterior
effect
lpsinduc
damag
cytokin
secret
block
overexpress
therefor
protect
effect
overexpress
lpsinduc
apoptosi
inflammatori
respons
may
regul
ma
receptor
fact
act
counterregul
ace
regul
product
angii
ang
addit
sarscov
infect
caus
downregul
express
lung
treatment
protect
mous
lung
sever
acut
injuri
also
note
express
lung
tissu
downregul
mous
ard
model
induc
acid
aspir
endotoxin
periton
sepsi
studi
loss
express
mutant
mice
result
sever
lung
injuri
enhanc
vascular
permeabl
increas
lung
edema
worsen
lung
function
found
angii
level
cell
supernat
higher
lp
stimul
lp
stimul
addit
overexpress
revers
imbal
significantli
reduc
angii
increas
ang
level
thu
reduc
lpsinduc
apoptosi
inflamm
contrast
shrnainhibit
express
aggrav
imbal
markedli
increas
angii
decreas
ang
level
promot
apoptosi
inflammatori
respons
caus
lp
exposur
ma
receptor
blocker
effect
abolish
protect
effect
transgenesi
imbal
affect
treatment
ma
receptor
blocker
lp
stimul
also
significantli
increas
angii
obviou
influenc
ang
level
may
ascrib
signific
suppress
express
ma
receptor
blocker
therefor
protect
effect
lpsinduc
pmvec
injuri
may
via
regul
ma
receptor
fact
mani
report
suggest
angii
exert
proinflammatori
effect
induc
releas
cytokin
chemokin
adhes
molecul
growth
factor
reactiv
oxygen
speci
receptor
angii
also
significantli
induc
apoptosi
pulmonari
endotheli
cell
receptor
lead
damag
epitheli
barrier
function
increas
permeabl
hand
ang
bind
specif
gproteincoupl
receptor
ma
counteract
angii
function
ie
vasodilatori
antigrowth
antiprolif
effect
overexpress
ang
prevent
bleomycininduc
lung
injuri
blockad
ma
receptor
abolish
benefici
effect
ang
monocrotalineinduc
pulmonari
hypertens
ang
attenu
ventilatoror
acid
aspirationinduc
lung
injuri
barrier
failur
pmvec
effect
block
ma
receptor
blocker
moreov
experiment
result
also
indic
unbalanc
angiiang
associ
develop
ard
chang
angiiang
close
relat
ratio
ace
bronchoalveolar
lavag
fluid
balf
ventil
anim
expos
lp
activ
reduc
wherea
ace
activ
enhanc
chang
accord
enhanc
balf
level
angii
reduc
level
ang
hindlimb
overexpress
effect
reduc
lpsinduc
sapkjnk
phosphoryl
level
phosphoryl
unaffect
contrast
downregul
lpsexpos
cell
obvious
enhanc
phosphoryl
level
fail
chang
sapkjnk
phosphoryl
b
f
phosphoryl
level
sapkjnk
significantli
enhanc
pretreat
prior
lp
stimul
overexpress
pretreat
obvious
downregul
level
sapkjnk
phosphoryl
slightli
decreas
phosphoryl
level
data
express
mean
sd
p
compar
control
group
p
compar
lp
group
p
compar
lp
group
p
compar
lp
group
ischemiareperfus
imbal
local
lung
tissu
accompani
chang
angiiang
thu
believ
imbal
ma
receptor
mediat
lung
injuri
regul
ra
homeostasi
may
improv
lpsinduc
lung
injuri
activ
mapk
pathway
key
role
progress
acut
lung
injuri
fulli
elucid
pmvec
exposur
lp
present
studi
found
overexpress
significantli
block
lpsinduc
activ
jnk
pathway
strikingli
prevent
administr
ma
receptor
blocker
suggest
protect
lpsinduc
apoptosi
pmvec
inflamm
perhap
ang
ma
pathway
modul
jnk
phosphoryl
hand
enhanc
lpsinduc
erk
phosphoryl
influenc
jnk
phosphoryl
wherea
lpsmediat
increas
erk
phosphoryl
affect
overexpress
cell
pretreat
ma
receptor
blocker
result
suggest
inhibit
aggrav
lpsinduc
pmvec
apoptosi
inflamm
mainli
pathway
enhanc
erk
phosphoryl
fact
activ
mapk
erk
associ
tnfainduc
increas
permeabl
pulmonari
endotheli
cell
prolifer
surviv
lung
endotheli
cell
maintain
endotheli
monolay
integr
may
way
activ
mapk
bleomycin
induc
cell
apoptosi
jnk
phosphoryl
pathway
alveolar
epitheli
cell
aec
addit
regul
balanc
angii
ang
inhibit
apoptosi
alveolar
epitheli
cell
blockad
jnk
phosphoryl
also
perform
addit
experi
determin
whether
ma
axi
prevent
lpsinduc
inflammatori
respons
apoptosi
rat
pmvec
via
inhibit
jnk
phosphoryl
found
protect
effect
overexpress
lpsinduc
apoptosi
enhanc
jnk
inhibitor
deterior
erk
inhibit
jnk
inhibitor
markedli
reduc
apoptosi
cytokin
secret
pmvec
delet
pretreat
ma
receptor
antagonist
ma
receptor
antagonist
abolish
protect
effect
aggrav
erk
inhibitor
revers
jnk
inhibit
therefor
data
suggest
ma
may
protect
effect
lpsinduc
apoptosi
inflamm
pmvec
mainli
inhibit
jnk
pathway
present
studi
found
overexpress
significantli
inhibit
lpsinduc
activ
nfkb
degrad
ikba
protein
strikingli
revers
ma
receptor
antagonist
addit
downregul
pretreat
enhanc
nfkb
phosphoryl
fur
h
caus
signific
increas
phosphoryl
nfkb
decreas
level
ikba
pmvec
overexpress
effect
reduc
lpsinduc
nfkb
phosphoryl
level
revers
ikba
level
contrast
downregul
lpsexpos
cell
obvious
enhanc
nfkb
phosphoryl
level
suppress
ikba
level
phosphoryl
nfkb
downregul
ikba
significantli
enhanc
pretreat
prior
lp
stimul
pretreat
markedli
revers
effect
overexpress
nfkb
phosphoryl
ikba
express
data
express
mean
sd
p
compar
control
group
p
compar
lp
group
induc
apoptosi
enhanc
deterior
markedli
reduc
apoptosi
pmvec
delet
ma
receptor
blocker
pretreat
ma
receptor
blocker
abolish
protect
effect
aggrav
also
data
express
mean
sd
p
compar
pb
control
group
p
compar
lp
group
pretreat
affect
lpsinduc
tnfa
secret
c
preincub
especi
significantli
suppress
secret
cytokin
lp
group
e
f
pmvec
expos
lp
pretreat
caus
signific
increas
tnfa
secret
slightli
reduc
well
markedli
attenu
g
h
lpsinduc
tnfa
secret
lp
group
significantli
inhibit
preincub
affect
data
express
mean
sd
wwwnaturecomscientificreport
ther
degrad
ikba
protein
suggest
nfkb
pathway
also
import
prevent
ma
lpsinduc
pmvec
apoptosi
inflamm
fact
nfkb
bind
ikba
cytoplasm
dissoci
ikba
nfkb
activ
transloc
nucleu
upregul
transcript
sever
inflammatori
gene
nfkb
cascad
pivot
intracellular
signal
pathway
involv
apoptosi
inflammatori
respons
activ
nfkb
central
regul
pulmonari
inflamm
involv
pathogenesi
ard
lpsinduc
lung
injuri
associ
activ
mapk
nfkb
signal
pathway
inhibit
erk
protect
lpsinduc
lung
injuri
inhibit
nfkb
pathway
pretreat
ang
prevent
angiiinduc
lung
fibroblast
apoptot
resist
inhibit
mapknfkb
pathway
conclus
result
suggest
abnorm
activ
ra
unbalanc
angiiang
level
induc
imbal
express
close
relat
lpsmediat
apoptosi
inflamm
pmvec
furthermor
exert
protect
effect
lpsinduc
apoptosi
inflamm
pmvec
suppress
jnknfkb
signal
pathway
find
impli
may
appli
improv
lpsinduc
lung
injuri
via
regul
ma
receptor
inhibit
jnknfkb
signal
pathway
upregul
ma
axi
inhibit
jnknfkb
activ
may
effect
therapeut
strategi
ard
clinic
limit
studi
result
address
crosstalk
mapk
nfkb
signal
pathway
studi
necessari
investig
possibl
crosstalk
among
intracellular
signal
pathway
involv
effect
ang
ma
receptor
lpsinduc
pmvec
apoptosi
administr
ang
pmvec
expos
lp
vitro
addit
whether
ang
ma
receptor
lead
prevent
acut
lung
injuri
mapknfkb
signal
pathway
vivo
address
